Exponential regression of CA 125 during salvage treatment of ovarian cancer with taxol.
Gynecol. Oncol., Jun;53(3):339-43 (1994)
Vulvar melanoma: a report of 20 cases and review of the literature.
J. Am. Acad. Dermatol., Apr;50(4):554-62 (2004)
Vulvar melanoma: review of diagnosis, staging, and therapy.
J Low Genit Tract Dis., Jan;8(1):58-69 (2004)
Treatment of refractory ovarian carcinoma with paclitaxel and cisplatin after treatment failure with single-agent paclitaxel.
Eur. J. Gynaecol. Oncol., 16(6):439-47 (1995)
Recurrent cervical squamous cell carcinoma in an ovary following ovarian conservation and radical hysterectomy.
Gynecol. Oncol., Apr;41(1):64-6 (1991)
A comparison of staging systems for squamous cell carcinoma of the vulva.
Gynecol. Oncol., Oct;47(1):34-7 (1992)
Synchronous dual primary ovarian and endometrial carcinomas.
Int J Gynaecol Obstet., Dec;43(3):305-12 (1993)
Absence of an association between G-CSF support and clinical response in heavily pre-treated ovarian cancer patients receiving salvage chemotherapy with paclitaxel (Taxol).
Eur. J. Gynaecol. Oncol., 16(4):251-7 (1995)
Absence of cumulative bone marrow suppression in heavily pretreated ovarian cancer patients undergoing salvage chemotherapy with paclitaxel.
Oncology., 52(5):407-12 (1995)